Trinity to discuss acquisition in conference call

Trinity Biotech will host a conference call to discuss its recent acquisition of bioMerieux’s coagulation division at 4pm Irish time today.

Trinity to discuss acquisition in conference call

Trinity Biotech will host a conference call to discuss its recent acquisition of bioMerieux’s coagulation division at 4pm Irish time today.

Trinity, listed on the ISEQ and on the NASDAQ, is a developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited